TIDE Trial Halts Pending FDA Review
- Cardio
- 01/04/2012
GlaxoSmithKline confirmed today that it will suspend enrolment of new patients in the Thiazolidinedione Intervention with Vitamin D Evaluation (TIDE) clinical trial at the request of the U.S....
READ MORE